Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared.

The U.S. Food and Drug Administration has approved Regeneron's cancer therapy, the company said on Wednesday, providing ...

Researchers have identified ways in which chemotherapy can damage healthy cells and found that some drugs can add decades of ...

A routine blood test may be able to detect cancer more than three years before diagnosis, a new study suggests. In the study, ...

To develop the test, researchers analyzed 6553 blood samples, 3076 from patients with cancer and 3477 from healthy ...

What counts in life is not the mere fact that we have lived. It is what difference we have made to the lives of others.

A 2022 study claims to have found that a certain blood type is linked to a higher risk of colorectal cancer. Colorectal ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.